Commercial risk will be a critical catalyst of progress – it’s complicated, but is it possible? We think so.



What’s the “New Normal” for Health System Purchasing?

The waves of Covid-19 cases have exposed major vulnerabilities in our health care supply chain —not just in terms of PPE shortages, but also in terms of upstream operations and sustainable access to products. These events upended the status quo partnerships and expectations between providers and suppliers.

We go deep in these topics to provide you with customer insight in:

  • Supply chain operations
  • Value analysis committee processes
  • Health system-supplier partnerships evaluations

Fill out the form to speak with a representative and learn more about Advisory Board research


The new health care supply chain mandate

Listen in as Erin Lane, Director - Life Sciences and Health Care Ecosystem Research, talks through our latest insights, research, and thinking into how America's Covid-19 response has changed how health systems evaluate and partner with suppliers.

About Advisory Board

For more than 40 years, we've helped executives and future leaders in health care work smarter and faster by providing provocative insights, actionable strategies, and practical tools to support execution.

With 40+ years of experience, a team of 250+ experts, and a network of 4,900+ member organizations that span the payer, provider, and supplier industries, we support life sciences firms’ commercial and medical leaders with research and educational resources that develop market strategy, enrich customer insight, and more.

More for Life Science Commercial Leaders

More for Health Care Technology Leaders

More for Health Care Suppliers

Have a Question?


Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.